key: cord-0274247-sdem1g8c
authors: Waterlow, N. R.; Toizumi, M.; van Leeuwen, E.; Nguyen, H.-A. T.; Myint-Yoshida, L.; Eggo, R. M.; Flasche, S.
title: Evidence for Influenza and RSV interaction from 10 years of enhanced surveillance in Nha Trang, Vietnam, a modelling study.
date: 2021-10-26
journal: nan
DOI: 10.1101/2021.10.19.21265189
sha: c1124866d1f2fd256849eac25114c7906280fa74
doc_id: 274247
cord_uid: sdem1g8c

Influenza and Respiratory Syncytial Virus (RSV) interact within their host posing the concern for heterologous ecological changes following vaccination. We aimed to estimate the population level impact of their interaction. We developed a dynamic age-stratified two-pathogen mathematical model that includes pathogen interaction through competition for infection and enhanced severity of dual infections. We used parallel tempering to fit it's parameters to 11 years of enhanced hospital-based surveillance for acute respiratory illnesses (ARI) in children under 5 years old in Nha Trang, Vietnam. The data supported either a 41% (95%CrI: 36 - 54) reduction in heterologous acquisition during infection and for 10.0 days (95%CrI 7.1 -12.8) thereafter, or no cross protection. We estimate that co-infection increased the probability for an infection in <2y old children to be reported 7.2 fold (95%CrI 5.0 - 11.4); or 16.6 fold (95%CrI 14.5 - 18.4) in the respective scenarios. Absence of either pathogen was not to the detriment of the other. We find stronger evidence for severity enhancing than for acquisition limiting interaction. In this setting vaccination against either pathogen is unlikely to have a major detrimental effect on the burden of disease caused by the other.

Abstract: Influenza and Respiratory Syncytial Virus (RSV) interact within their host posing 31 the concern for heterologous ecological changes following vaccination. We aimed to estimate 32 the population level impact of their interaction. 33 34 We developed a dynamic age-stratified two-pathogen mathematical model that includes The impact of vaccination may be enhanced if co-infections increase the propensity of severe 58 disease beyond that of either pathogen 4 . However, the impact of vaccination may be lessened 59 if vaccination reduces competitive pressure between influenza and RSV and thus leads to 60 increased circulation of the other pathogen. Such competitive pressure has been observed in 61 the form of cross protection in mouse studies that showed e.g. a protective effect of live 62 attenuated influenza vaccine administration on RSV replication 5 and influenza infection on 63 RSV severity 6 , mediated by the innate immune system. Population level evidence for the 64 effect of cross-protection on influenza and RSV epidemiology, however, is largely of 65 observational nature: a lack of coincidence in peak timings 7,8 , changes in RSV peak timing 66 following unusual influenza seasons 9-14 and alternating infection patterns 15 . 67 68 Cross-protection could occur through a variety of mechanisms including viral competition for 69 resources in the host 16 , the activation of the innate immune system such as through toll-like 70 receptors (TLRs) 3 and 7 17,18 or short term immune memory through surviving cells in an 71 antiviral state (e.g. epithelial cells following influenza infection 19 ). Estimates of the duration 72 of cross-protection and its biological pathway vary. Experimental infection of ferrets 73 estimated less than 2 weeks protection between influenza A and B viruses 20 , yet cells forming 74 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, RSV cases) of these were dual infections ( Figure 1A&B ). The mean age of at admission was 90 22 months and 16 months for influenza and RSV cases respectively. RSV notifications 91 showed strong consistent seasonality across years, peaking usually in the 34th week of the 92

year, whereas influenza showed less seasonality, but typically occurs after Tết Nguyên Đán 93 holidays and before the RSV epidemic ( Figure 1C) . 94 95 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, There was a small, not statistically significant, negative correlation between weekly influenza 96 and RSV incidence, with the Pearson correlation coefficient -0.074 (95% CrI:-0.160 to 97 0.009). ( Figure S1 ) 98 99 We estimated that in order to observe the weekly reported number of dual infections when 100 assuming independence of influenza and RSV infection, the annual RSV attack rate needed to 101 be 720% (95% CrI: 560 -1000) in ages 0-1y and 430% (95% CrI: 270 -980) in ages 2-4y. 102

The high attack rate suggests that in fact influenza and RSV infections are not independent 103 but that co-infection is likely to substantially enhance the propensity for hospitalisation with 104 ARI in this setting. 110 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, Model inference 111 We developed an age-stratified two-pathogen mathematical model including pathogen 112 interaction (competition for acquisition and increased disease propensity during dual 113 infection), which was able to fit the case data for influenza and RSV well ( The main differences between modes for other parameters were in the detection rate of 123 influenza, which ranged from 13 to 21% of infections reported (supplement section 8) and the 124 increased reporting for dual infections. We estimate that in the moderate competition mode 125 the observation of influenza and RSV coinfection among ARI cases was 8.2 (95%CrI 6.9 -126 9.9) times more likely than would have been expected by chance in ages 2-4 and 16.6 127 (95%CrI 14.5 -18.4) in ages 0-1. This compares to the no competition scenario where the 128 observation of influenza and RSV coinfection among ARI cases was 3.6 (95%CrI 2.5 -5.8) 129 and 7.2 (95%CrI 5.0 -11.4) times more likely than would have been expected by chance in 130 ages 2-4 and 0-1 respectively. 131

To assess the relevance of RSV and influenza interaction on population level in this setting 133 we simulated single pathogen versions of the parameterised model. In the case of no 134 competition, absence of influenza (e.g. through widespread vaccination) reduced RSV 135 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share,

The copyright holder has placed this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.19.21265189 doi: medRxiv preprint 7 hospitalisations by 4.1% (95%CrI 3.3 -7.1%) due to a lack of co-infections with higher 136 propensity for severe disease and absence of RSV reduced influenza hospitalisations by 7.2% 137 (95%CrI 4.4-7.2%) in the study period. In the moderate competition mode, absence of 138 influenza reduced RSV hospitalisations by 5.7% (95%CrI 4.9 -6.5%) . In the absence of 139 RSV 1.8% (95%CrI -0.7 -7.2%) more hospitalised cases for influenza occurred ( Figure 2E ). matrices. In addition, we assume that risk of infection is age-dependent, but otherwise 194 homogeneous. However, increased risk of influenza infection may be correlated with 195 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, Our model does not take into account different subtypes of influenza or RSV, due to the 207 added complexity, additional parameters required and the lack of subtype specific data. We 208 therefore assume that any cross-protection between influenza and RSV does not vary by 209 subtype. We account for different immunity levels to circulating influenza subtypes by fitting 210 a susceptibility parameter at the start of each season. This is necessary because we fit to each 211 season, rather than including immunity waning and fitting over the time period combined. 212

While the start weeks of our season are fixed manually, we account for any impacts of this by 213 fitting the proportion infected at the start of each season for each virus. While most of the 214 posterior estimates are reasonable, the reporting rate for influenza infections is high, between 215 13 and 21%, compared to estimated 12% from data in Yoshida et al. (2013) . However, many 216 milder cases (including outpatients) are included in the reports as they may seek healthcare at 217 the hospital, thereby increasing the expected reporting rate in this context . Overall therefore, 218 our model estimates fit the data well, as well as known aspects of influenza and RSV 219 reuse, remix, or adapt this material for any purpose without crediting the original authors. infections (equations 1-3). We estimate the RSV attack rate rather than the influenza attack 259 rate, as RSV is more consistent year on year (see supplement section 1 for influenza 260 equivalent). Using a negative binomial likelihood with Brent optimization we estimated the 261 RSV reporting rate that would correspond to the maximum likelihood of observing the 262 reported weekly number of dual infections. We then used this estimate of the reporting rate to 263 calculate the annual RSV population attack rate required in order to observe this many 264 coinfected ARI admissions. The credible intervals for the attack rate were calculated using 265 the Hessian matrix from the optimisation. If the estimated attack rate is high, this may 266 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share,

The copyright holder has placed this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.19.21265189 doi: medRxiv preprint suggest that influenza and RSV co-infection increase severity (and hence reporting). If the 267 estimated attack rate is low, this could suggest that co-infection is less likely that at random 268 due to competition between the viruses. . For RSV we assume the only immunity at the beginning of the season is the 300 age-specific reduction in susceptibility (leaky immunity), as immunity to reinfection typically 301 lasts less than a year 38 . Due to infections in previous influenza seasons and potential 302 vaccination, susceptibility to influenza is assumed to decline exponentially at rate with age 303 (see supplement section 6). This is modelled as non-leaky cross-protection, due to the 304 combination of different exposures. Due to the short-time period modelled (max 66 weeks), 305 we do not include births, deaths or ageing, but instead hold the age-group specific population 306 sizes constant at the levels of 2010. Parameter definitions and values are shown in Table 1 

= 1 =2 =1

(4) 320

Where are the reported infections, are the parameters, j are the two age groups 0-1 and 2-4, 321 and i are the weeks, with n being the total number of weeks. NB is the likelihood of the 322 observed number of cases being a random draw from a negative binomial distribution with 323 the total number of modelled infections as the mean, , and the fitted overdispersion 324 parameter, k. MN is the multinomial likelihood, with pRSV, pFlu and pDual being the 325 respective probabilities of the infection with influenza, RSV or both, calculated from the ratio 326 of model reported cases. 327 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, 

VIRAL PATHOGENS ASSOCIATED WITH ACUTE RESPIRATORY 451 INFECTIONS IN CENTRAL VIETNAMESE CHILDREN

Predicting the impact of pneumococcal conjugate vaccine 454 programme options in Vietnam

Association of RSV-A ON1 genotype with Increased Pediatric Acute 456

Modeling epidemics caused by respiratory syncytial 458 virus (RSV)

Virus Infections, Reinfections and Immunity

A Bayesian MCMC 462 approach to study transmission of influenza: application to household longitudinal data

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental 465 Human Influenza

Characterizing the Epidemiology of the 2009 Influenza A/H1N1 467 Pandemic in Mexico

Estimating influenza latency and infectious period durations using viral 469 excretion data

Modelling the 471 Seasonal Epidemics of Respiratory Syncytial Virus in Young Children

Respiratory syncytial virus infections in 474 infants: quantitation and duration of shedding

Cocirculating Pathogens, and Its Impact on Surveillance

 345 We assessed the sensitivity of our estimates of the strength of interaction of influenza and 346 RSV to the prior on the interaction parameter and to the reporting rates of dual infections. We 347 reran the model with a prior on the interaction parameter for strong interaction, using a 348 normal distribution with mean 0.8 and standard deviation of 0.15. In addition, we ran a 349 version of the model where the reporting rate for dual infections and RSV was the same, as it 350 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, 450 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, 484 485 reuse, remix, or adapt this material for any purpose without crediting the original authors. this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share,The copyright holder has placed this version posted October 26, 2021. ; https://doi.org/10.1101/2021.10.19.21265189 doi: medRxiv preprint